Dear AuntMinnie Member,
As many imaging facilities begin to install their second and even third generation of PACS technology, migrating legacy data from older PACS networks to new systems is becoming an increasingly thorny issue.
One of the biggest hurdles comes despite the almost universal use of the DICOM standard: PACS is not a plug-and-play technology. Many PACS vendors use proprietary data storage schemes and other technological tricks that can make it tough for their customers to cut the cord.
Fortunately, there are strategies you can adopt to make PACS data migration less of a headache, and that's the topic of a new article by PACS consultant Michael Gray that we're featuring this week in our PACS Digital Community. Mr. Gray outlines a proactive approach that you can take to avoid the PACS data migration headache every time you change PACS vendors. Read all about it by clicking here.
In other news we're highlighting in our CT Digital Community, read about clinical results from a big new study on CT lung screening that finds that CT can find curable cancers, and find them in time to have an impact on survivability rates. The results were published today in the New England Journal of Medicine by Dr. Claudia Henschke and colleagues as part of the International Early Lung Cancer Action Program (I-ELCAP).
The researchers found that 85% of the cancers detected by annual CT lung screening were stage I malignancies, and that 92% of these patients who underwent resection were still alive five years later. Are the results powerful enough to justify the use of CT lung screening in at-risk populations? Find out more by clicking here.
